OptiBiotix signs distribution agreement for Greece and Cyprus
22nd Nov 2018 16:00
(Sharecast News) - Life sciences business OptiBiotix Health has entered into a three-year distribution agreement with an unnamed company to exclusively distribute and commercialise its own-label 'CholBiome' products containing its cholesterol and blood pressure reducing 'LPLDL' strain in Greece and Cyprus.
Read moreOptiBiotix enters three-year distribution deal with Bulgarian partner
26th Sep 2018 13:47
(Sharecast News) - Life sciences business OptiBiotix Health has entered into a three-year distribution agreement with an unnamed Bulgarian company to exclusively distribute and commercialise its own-label 'CholBiome' products, containing its cholesterol and blood pressure reducing 'LPLDL' strain in Bulgaria, it announced on Wednesday.
Read moreOptiBiotix inks licence agreement with Taiwanese probiotics outfit
10th Sep 2018 09:12
(Sharecast News) - OptiBiotix Health has inked a non-exclusive licence agreement for its cholesterol and blood pressure-reducing LPLDL products with Taiwanese probiotics outfit Bened Biomedical.
Read moreOptiBiotix Health signs big new US partnership
4th Sep 2018 07:31
(Sharecast News) - Life sciences business OptiBiotix Health has entered into an agreement with an unnamed US company for the use of its cholesterol-reducing 'Lactobacillus plantarum' strain as a pharmaceutical drug product, it announced on Tuesday.
Read moreOptibiotix Health swings to loss despite 'exciting' period
30th Aug 2018 09:23
(Sharecast News) - Biotechnology firm Optibiotix Health on Thursday reported that it swung to a loss for the six months ended 31 May even as it won seven new manufacturing and supply agreements across what it termed as an "exciting" period.
Read moreOptiBiotix Health invests £75,000 in The Health Weight Loss Company
3rd Jan 2017 09:54
(ShareCast News) - AIM-listed life science company OptiBiotix Health has increased its investment in its subsidiary, The Health Weight Loss Company, to support marketing and increase stock levels. The company made a £75,000 investment, which increases its stake in The Health Weight Loss Company to 6
Read moreOptiBiotix Health invests further in SkinBiotix
20th Oct 2016 11:03
(ShareCast News) - OptiBiotix Health has increased its investment in majority-owned subsidiary SkinBiotix Ltd via a £400,000 Convertible Loan Agreement. The investment provides SkinBiotix funding to complete the development and human studies for its first product application, in addition to funding
Read moreGeorgian Mining drill programme intercepts more copper and gold
20th Oct 2016 11:01
(ShareCast News) - Georgian Mining Corporation reported on Thursday that continued drilling at the Kvemo Bolnisi Project in Georgia has intercepted additional significant near-surface copper and gold sulphide mineralisation. The AIM-traded firm said the significant new drill intercepts included KED0
Read moreOptiBiotix appoints Martin Hunt chairman of subsidiary SkinBiotix
5th Oct 2016 11:43
(ShareCast News) - AIM-listed life science company OptiBiotix Health appointed industry veteran Martin Hunt chairman and director of its majority-owned subsidiary SkinBiotix. Hunt has experience in the life sciences sector from large multi-nationals to AIM-listed companies at MDY Healthcare, Videreg
Read moreOptiBiotix trumpets success of weight loss products
6th Sep 2016 08:58
(ShareCast News) - OptiBiotix Health, a life sciences business developing compounds to tackle obesity, high cholesterol, diabetes and skin care, announced the results of an independent consumer survey of its GoFigure products on Tuesday. The AIM-traded firm said the products, in the form of meal rep
Read moreOptiBiotix Health reports wider first half loss
25th Aug 2016 12:26
(ShareCast News) - OptiBiotix Health's shares dropped on Thursday as the medical product developer reported a wider first half loss. In the six months to the end of May, the loss before tax widened to £713,772 from £514,424 the same period a year earlier as administrative expenses grew to £802,0
Read moreOptiBiotix Health snacks now available at UK Whole Foods
9th Aug 2016 14:42
(ShareCast News) - AIM-listed OptiBiotix Health said its GoFigure meal replacement shakes and natural snack bars are now available at Whole Foods Market stores in the UK. The life sciences company, which develops compounds to tackle obesity, high cholesterol and diabetes, said GoFigure products will
Read moreOptiBiotix appoints director of business development
2nd Aug 2016 13:37
(ShareCast News) - AIM-listed OptiBiotix Health has announced the appointment of Luis Gosalbez as director of business development with immediate effect. The company, which develops compounds to tackle obesity, high cholesterol, diabetes and skin care, said Gosalbez brings a strong scientific backgr
Read moreOptiBiotix launches healthy food range, buys majority of partner
26th Jul 2016 12:16
(ShareCast News) - Obesity, high cholesterol, diabetes and skin care focused life sciences company OptiBiotix Health announced on Tuesday the successful completion of a trial launch for its Slimbiome ingredients in a range of meal replacement shakes and natural snack bars. The AIM-traded firm also r
Read moreOptiBiotix raises £1m in new placing
5th Feb 2016 09:55
(ShareCast News) - OptiBiotix had an additional £1m to play with on Friday, announcing a new placing of 1,282,051 ordinary shares at 78p each. The AIM-traded life sciences company, which specialises in products treating obesity, high cholesterol and diabetes, said the placing shares were issued to f
Read more